Literature DB >> 16924414

Targeting the hypoxia inducible factor pathway with mitochondrial uncouplers.

Rusha Thomas1, Myoung H Kim.   

Abstract

Hypoxia inducible factor-1 (HIF-1) is central to most adaptation responses of tumors to hypoxia, and consists of a hypoxia inducible HIF-1alpha or -2alpha subunit, and a constitutively expressed HIF-1beta subunit. Previously, mitochondrial uncouplers, rottlerin and FCCP, were shown to increase the rate of cellular O(2 )consumption. In this study, we determined that mitochondrial uncouplers, rottlerin and FCCP, significantly decreased hypoxic as well as normoxic HIF-1 transcriptional activity which was in part mediated by down-regulation of the oxygen labile HIF-1alpha and HIF-2alpha protein levels in PC-3 and DU-145 prostate cancer cells. Our results also revealed that mitochondrial uncouplers decreased the expression of HIF target genes, VEGF and VEGF receptor-2. Taken together, our results indicate that functional mitochondria are important in HIF-1alpha and HIF-2alpha protein stability and transcriptional activity during normoxia as well as in hypoxia, and that mitochondrial uncouplers may be useful in the inhibition of HIF pathway in tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924414     DOI: 10.1007/s11010-006-9295-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.

Authors:  B H Jiang; J Z Zheng; S W Leung; R Roe; G L Semenza
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

5.  Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species.

Authors:  Clara Schroedl; David S McClintock; G R Scott Budinger; Navdeep S Chandel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11       Impact factor: 5.464

6.  Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?

Authors:  Kevin D Burroughs; Jennifer Oh; J Carl Barrett; Richard P DiAugustine
Journal:  Mol Cancer Res       Date:  2003-02       Impact factor: 5.852

Review 7.  Mitochondrial state 3 to 4 respiration transition during Fas-mediated apoptosis controls cellular redox balance and rate of cell death.

Authors:  Oren Tirosh; Anna Aronis; J Andr's Melendez
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

8.  Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.

Authors:  Hua Zhong; Gregg L Semenza; Jonathan W Simons; Angelo M De Marzo
Journal:  Cancer Detect Prev       Date:  2004

Review 9.  HIFs and tumors--causes and consequences.

Authors:  Gisele Höpfl; Omolara Ogunshola; Max Gassmann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-04       Impact factor: 3.619

10.  Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha.

Authors:  Thilo Hagen; Cormac T Taylor; Francis Lam; Salvador Moncada
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

View more
  5 in total

1.  Mammea E/BB, an isoprenylated dihydroxycoumarin protonophore that potently uncouples mitochondrial electron transport, disrupts hypoxic signaling in tumor cells.

Authors:  Lin Du; Fakhri Mahdi; Mika B Jekabsons; Dale G Nagle; Yu-Dong Zhou
Journal:  J Nat Prod       Date:  2010-10-07       Impact factor: 4.050

2.  Structures and mechanisms of antitumor agents: xestoquinones uncouple cellular respiration and disrupt HIF signaling in human breast tumor cells.

Authors:  Lin Du; Fakhri Mahdi; Sandipan Datta; Mika B Jekabsons; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2012-08-31       Impact factor: 4.050

3.  SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer.

Authors:  Rusha Thomas; Nima Sharifi
Journal:  Mol Cancer Ther       Date:  2011-12-15       Impact factor: 6.261

4.  HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells.

Authors:  Rusha Thomas; Myoung H Kim
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

5.  Acute inhibition of selected membrane-proximal mouse T cell receptor signaling by mitochondrial antagonists.

Authors:  Kwangmi Kim; Lin Wang; Inkyu Hwang
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.